The unfavorable effects of transthyretin on T2DM could be partly attributed to indirectly elevated contents of RBP4, which appeared to be positively associated with prediabetes, T2DM, and other obesity-associated diseases in various animal and epidemiologic studies [32,33,34,35,36]. This evidence concerns the gene RBP4 and prediabetes syndrome.